Diaceutics
Data-driven diagnostics tools for the pharmaceutical and medical sectors, mostly in cancer diagnostics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 | round | |
* | £1.0m | Grant | |
| Total Funding | 000k | ||
| GBP | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 10 % | 40 % | 22 % | 36 % | 25 % | 25 % | 19 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 17 % | 19 % | 10 % | 9 % | 18 % | 22 % | 24 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 4 % | 4 % | (7 %) | (5 %) | - | 9 % | 14 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Diaceutics is a company focused on ensuring that patients receive the right treatment at the right time through precision medicine diagnostics. It serves leading pharmaceutical companies by providing an end-to-end solution for the launch of precision medicine diagnostics, enabled by its DXRX platform. DXRX is the first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs. Diaceutics' business model revolves around its data capabilities, global lab network, and a product suite tailored for precision testing. The company makes money by offering these integrated solutions to pharmaceutical companies, helping them to effectively commercialize diagnostic tests that are crucial for personalized medicine. Diaceutics operates in the healthcare and pharmaceutical market, specifically focusing on precision medicine and diagnostic testing. Its clients are primarily large pharmaceutical companies looking to enhance their diagnostic capabilities and ensure better patient outcomes.
Keywords: precision medicine, diagnostics, DXRX platform, pharmaceutical, global lab network, real-world data, personalized medicine, diagnostic testing, healthcare, commercialization.